YAP1 and hepatocellular carcinoma: These results are consistent with a previous report by our laboratory demonstrating that the acute treatment of Sorafenib‐sensitive HCC cells with Sorafenib induces autophagy and apoptosis which is prevented by YAP/TAZ activities (Tang et al, 2019).